Leqvio (inclisiran) is a prescription medication designed to lower low-density lipoprotein (LDL) cholesterol, often referred to as bad cholesterol. It is specifically prescribed for adults with hypercholesterolemia, including heterozygous familial hypercholesterolemia (HeFH), an inherited condition that causes high cholesterol levels. This treatment is utilized in combination with a healthy diet and regular exercise to manage cholesterol levels effectively.
How Leqvio Works to Lower Cholesterol
Leqvio operates through a specific mechanism of action targeting the PCSK9 protein. The liver produces PCSK9, which naturally increases LDL cholesterol levels in the bloodstream. Leqvio works by reducing the production of this protein, thereby helping the liver clear more LDL cholesterol from the blood. While Leqvio is highly effective at lowering cholesterol numbers, clinical evidence is still developing regarding whether it directly reduces the risk of cardiovascular events like heart attacks or strokes.
Leqvio Dosage and Administration
Leqvio is administered as a subcutaneous injection by a healthcare professional in a medical setting. The standard dosing schedule begins with an initial injection, followed by a second dose three months later. After these first two doses, maintenance injections are administered once every six months. If a patient misses an appointment, they should reschedule immediately. If the missed dose is administered within three months, the regular schedule continues; otherwise, the two-dose initiation phase may need to be restarted.
Potential Side Effects of Leqvio
Like most prescription medications, Leqvio can cause side effects, though they are generally mild. The most common side effects include mild injection site reactions such as pain, redness, or warmth, as well as joint pain and bronchitis. Serious side effects are rare but can include severe injection site reactions or allergic reactions. Patients experiencing signs of a severe allergic reaction, such as breathing difficulties or swelling, require immediate medical attention.
Leqvio vs. Other Cholesterol Treatments
Leqvio is not a statin. Statins are oral medications that lower cholesterol through a different pathway. However, doctors frequently prescribe Leqvio alongside statins or other cholesterol-lowering drugs like ezetimibe to achieve optimal results. Leqvio also differs from PCSK9 inhibitors like Repatha or Praluent. While they target the same protein, Repatha and Praluent are injected more frequently, often every two to four weeks, and can sometimes be self-administered at home. Leqvio is not meant to be used simultaneously with other PCSK9 inhibitors.
Important Considerations Before Starting Leqvio
Before starting Leqvio, patients should discuss their medical history with their doctor. The safety of Leqvio during pregnancy has not been established. Since a developing fetus requires cholesterol, Leqvio is generally not recommended for pregnant individuals. It is also unclear if the drug passes into breast milk, so breastfeeding individuals should consult their healthcare provider. Additionally, Leqvio has not been extensively studied in patients with severe liver impairment, requiring careful medical evaluation before starting treatment.
Leave a Reply